Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Marsh

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Optimisation of a pyrazole series of progesterone antagonists; Part 1Kevin N Dack, Sarah Skerratt, Patrick S Johnson, et al.
Medical Physics|May 24, 2022
Validation of Monte Carlo <sup>131</sup> I radiopharmaceutical dosimetry workflow using a 3D-printed anthropomorphic head and neck phantomDavid P Adam, Joseph J Grudzinski, Ian Bormett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
Preclinical Pharmacokinetics and Dosimetry Studies of <sup>124</sup>I/<sup>131</sup>I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft ModelsIan R Marsh, Joseph Grudzinski, Dana C Baiu, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic DosimetryIan R Marsh, Chunrong Li, Joseph Grudzinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether AnalogDana C Baiu, Ian R Marsh, Alexander E Boruch, et al.
International Journal of Radiation Oncology, Biology, Physics|February 17, 2024
Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck CancerDavid P Adam, Joseph J Grudzinski, Ian R Marsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2025
Combination Radiopharmaceutical Therapy and Radiotherapy for Thyroid Cancer: Dosimetry-Driven Precision MedicineIan R Marsh, Harry Quon, Prasanna Santhanam, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Antitumor efficacy of <sup>90</sup>Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumorsHemanth K Potluri, Carolina A Ferreira, Joseph Grudzinski, et al.
Journal of Applied Clinical Medical Physics|August 27, 2024
Commissioning and validation of a single photon beam model in RayStation for multiple matched Elekta LinacsLin Su, Ellen Huang, Devin A Miles, et al.
Plos One|August 12, 2021
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) settingKara Magee, Ian R Marsh, Michelle M Turek, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|May 1, 2010
Optimisation of a pyrazole series of progesterone antagonists; Part 1Kevin N Dack, Sarah Skerratt, Patrick S Johnson, et al.
Medical Physics|May 24, 2022
Validation of Monte Carlo <sup>131</sup> I radiopharmaceutical dosimetry workflow using a 3D-printed anthropomorphic head and neck phantomDavid P Adam, Joseph J Grudzinski, Ian Bormett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
Preclinical Pharmacokinetics and Dosimetry Studies of <sup>124</sup>I/<sup>131</sup>I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft ModelsIan R Marsh, Joseph Grudzinski, Dana C Baiu, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 6, 2023
Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic DosimetryIan R Marsh, Chunrong Li, Joseph Grudzinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether AnalogDana C Baiu, Ian R Marsh, Alexander E Boruch, et al.
International Journal of Radiation Oncology, Biology, Physics|February 17, 2024
Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck CancerDavid P Adam, Joseph J Grudzinski, Ian R Marsh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2025
Combination Radiopharmaceutical Therapy and Radiotherapy for Thyroid Cancer: Dosimetry-Driven Precision MedicineIan R Marsh, Harry Quon, Prasanna Santhanam, et al.
Journal for Immunotherapy of Cancer|August 24, 2022
Antitumor efficacy of <sup>90</sup>Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumorsHemanth K Potluri, Carolina A Ferreira, Joseph Grudzinski, et al.
Journal of Applied Clinical Medical Physics|August 27, 2024
Commissioning and validation of a single photon beam model in RayStation for multiple matched Elekta LinacsLin Su, Ellen Huang, Devin A Miles, et al.
Plos One|August 12, 2021
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) settingKara Magee, Ian R Marsh, Michelle M Turek, et al.
Pageof 2